Jim is an excellent leader with more than a quarter a century of healthcare and investing experience. He is the founder of Foresite Capital. His motivation to start the company was the desire to combine elements of all aspects of his career to create a unique investment platform.
He focuses on operational, strategic and investment opportunities to build a franchise healthcare business. He has been the chief strategist at Foresite Capitals investment company structure and business strategy and played a significant role in several portfolio companies of Foresite Capital.
Before starting Foresite Capital, Jim cofounded two healthcare investment practices and two biopharmaceutical firms. Jim attended Harvard University medical and business schools. While finishing his college education at Harvard, he started GelTex Pharmaceuticals. The company introduced two drugs to the market for less than $80M. The company was bought in 1998 for $1.6 billion. At this time, the lead drug Renagel had an annual revenue rate of more than $200M. Currently, the drug is estimated to produce an annual income of close to a billion. Another company that Jim cofounded and served, as CEO is Theravance, Inc.
Other investment experience by Jim
- He was the creative partner of Prospect Scheme Partners II and III
- Collaborate at Sierra Endeavors where he helped kick-start its investment practice in healthcare
- Amira Pharmaceuticals, Amerigroup, and jazz pharmaceuticals
Jim graduated with a B.S. and B.S.E.E at Yale University. At Harvard, he graduated with an M.S from MIT and M.BA from the Harvard business school.
Foresite Capital was one of the investors who contributed to the $14M funding of Mindstrong Health, a startup that focuses on using smartphones to diagnose and help treat neuropsychiatric disorders. The startup has developed software that uses the patient’s patterns of typing and scrolling to measure brain function. It then provides info about the mood and cognition biomarkers that include memory, function, and processing speed.
According to Jim Tananbaum’s Medium.com post, the founders of Mindstrong Health have brought unmatched knowledge of the pressing challenges surrounding how the medical community cares for people suffering from cognitive health disorders.